Rationale: Surgical resection is the mainstay therapy for localized non-small cell lung cancer (NSCLC), yet elderly patients are less likely to be treated due to concerns about morbidity and mortality related to surgery. Objectives: To validate and refine a clinical model to predict 30-day perioperative mortality (POM) in elderly patients undergoing curative resection for lung cancer. Methods: We identified 14,297 patients aged 65 years and older with stage I, II, or IIIA NCSLC from the Surveillance, Epidemiology, and End-Results Registry linked to Medicare claims. We used logistic regression analysis to identify independent risk factors for POM and to validate and refine a previously derived prediction model. Measurements and Main Results: Overall, POM was 4.6% (95% confidence interval, 4.2-4.9%). Multiple regression analysis revealed that greater age, male sex, resections of multiple lobes, advanced stage, greater tumor size, and certain comorbidities were associated with increased risk for POM. These risk factors were similar to those observed in the prior model. When patients were stratified according to their predicted risk of POM, the observed mortality increased from 1.2 to more than 10%. Conclusions: Among elderly patients with lung cancer, a prediction rule can identify those patients at higher risk for fatal complications from surgery. Further studies should evaluate whether use of the model can lead to improvements in treatment decision making.
With a median age at diagnosis of 69 years, rates of lung cancer are increasing in elderly patients relative to the younger population (1, 2) . Lung resection is the mainstay therapy for non-small cell lung cancer (NSCLC) localized to the chest (stages I-IIIA), with 5-year survival rates of up to 70% for earlier stages (3) . However, surgical management of the elderly can be challenging due to increased frailty and a higher prevalence of comorbid conditions, and, for this reason, many physicians are more reluctant to recommend surgery for these patients (4, 5) . These factors may contribute to lower overall rates of resection among the elderly and an increased use of safer, yet potentially less effective, limited resections (6, 7) .
When making decisions regarding resection, physicians must balance the potential long-term benefits of surgery with the risk of surgery-related deaths, particularly among patients with multiple comorbid conditions or limited life expectancy. Some studies have shown that certain characteristics of the patient, the tumor, or the surgery are associated with increased 30-day perioperative mortality (POM) (8) (9) (10) . Using these risk factors, Strand and colleagues (11) developed a clinical rule to predict the risk of POM in patients undergoing resection for lung cancer. This predictive rule has several potential clinical implications. First, it could be used to assist physicians and patients make informed decisions regarding surgery. Second, it could help select high-risk patients who should undergo further testing before surgery and receive closer follow-up care in the postoperative period. Ultimately, high-risk patients identified by the rule could be the target of interventions to decrease POM. Conversely, the rule can be used to identify low-risk patients who otherwise may not be operated on because of their advanced age. However, before a predictive model can be applied to clinical practice, it should be externally validated among different patient populations to assess the generalizability of the model (12, 13) .
The aim of this study was to use data from a populationbased cancer registry to validate and refine a clinical model to predict 30-day POM among elderly patients undergoing curative resection for lung cancer.
METHODS
Since 1973, the Surveillance, Epidemiology, and End Results (SEER) program has collected clinicopathologic data on all incident cancer cases in specified geographic areas of the United States (14) . The SEER registry has been combined with Medicare claims to provide additional data on inpatient treatment, as well as outpatient physician services (15) . From SEER-Medicare, we selected all patients aged 65 years and older with histologically confirmed stages I-IIIA NSCLC who underwent surgical resection between 1991 and 2002. Additional information regarding the identification of cases, the coding of variables, and the statistical analysis is available in the online supplement.
Baseline sociodemographic information was obtained from SEER and Medicare databases. To obtain a summary measure of the burden of comorbidities within our sample population, we employed the Deyo adaptation of the Charlson comorbidity index (16) (17) (18) . Additionally, we created several dichotomous variables indicating the presence or absence of individual comorbidities. Stage was classified according to the American Joint Committee on Cancer criteria (19) . In terms of
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For elderly patients with lung cancer, the risk of perioperative mortality from resection is an important concern. A clinical rule can help physicians and patients make informed treatment decisions and anticipate potential complications from surgery.
What This Study Adds to the Field
Using a population-based cancer registry, we validated and refined a model to predict perioperative mortality in an elderly population undergoing lung cancer resection.
histology, cases were classified as adenocarcinoma, bronchoalveolar cell carcinoma, squamous, or large-cell carcinoma (20) . Patients were grouped by their type of resection according to the SEER site-specific codes (segmentectomy, wedge resection, lobectomy, bilobectomy, pneumonectomy, and chest wall resection with lung resection [en bloc resection]). Chemotherapy and radiotherapy use was ascertained using previously reported codes (21, 22) .
The outcome of the study, POM, was defined as death within 30 days of surgery. The date of surgery was identified from inpatient Medicare files, and the date of death was obtained from Medicare, which receives this information from the U.S. Social Security Administration.
Statistical Analysis
Differences in distribution of sociodemographic and tumor characteristics, comorbidities, and type of surgery between patients who died within 30 days of surgery and those that did not were evaluated using the Chi-square test. To validate the model published by Strand and colleagues (11), we fitted a logistic regression model using the same covariates included in the previous study. To refine the model, we evaluated whether the addition of some of the variables that were associated with 30-day POM in the univariate analysis, or the inclusion of individual comorbidities (instead of the summary score), improved the model's predictive ability. These models were compared in terms of discrimination using the area under the curve or the c statistic. The Akaike information criteria (AIC) and the Hosmer and Lemeshow test were used to assess the goodness of fit of the different models (23, 24) . Once the final model was fitted, we divided patients into quintiles of increasing predicted probability of POM. The predicted and observed POM was compared for each quintile. All analyses were performed using the SAS statistical software program (SAS Institute Inc., Cary, NC).
RESULTS
Of the 14,297 patients in the study cohort, 72% had stage I, 14% had stage II, and 14% had stage IIIA NSCLC. Lobectomy was the most common procedure, comprising 74% of the surgeries. Overall, 655 patients (4.6%; 95% confidence interval [CI], 4.2-4.9%) died within 30 days of surgery. POM rates were 4.1% for limited resection, 3.7% for lobectomy, and 13.1% for pneumonectomy (P , 0.001). The baseline patient characteristics are summarized in Table 1 . Greater age (P , 0.001) and male gender (P , 0.001) were significantly associated with increased 30-day POM. Additionally, patients with squamous cell carcinomas had higher rates of 30-day mortality compared with those with adenocarcinoma (P , 0.001). POM also increased with tumor size (P , 0.001) and stage (P , 0.001).
Having multiple comorbid conditions increased 30-day POM, with 14% of those who died having a Charlson comorbidity score greater than 4, as opposed to 8% of the patients who did not experience POM events (P , 0.001). When evaluated as individual conditions, a history of acute myocardial infarction (P , 0.001) was the comorbidity with the strongest association for risk of postoperative death, although many other conditions affected surgical outcomes as well.
Validation of POM Prediction Model
As shown in Table 2 , we obtained comparable results to those reported by Strand and colleagues (11) when we fitted a model using the same covariates. Overall, there was considerable agreement in terms of the significance of predictor variables, as well as the strength of association between each factor and the risk of POM. Similar to Strand and colleagues (11) 
Refinement of the Predictive Model
Once we confirmed the validity of the model, we assessed whether inclusion of other key predictors or a different categorization of some variables could improve the model's predictive performance. As shown in Figure 1 , the initial validation of the model yielded a c statistic of 0.709 and an AIC of 5,006. We found the highest c statistic (0.724) and lowest AIC value (4,955) with a model that included the original variables as well as individual comorbidities, instead of the summary comorbidity score. To simplify the model, we limited the comorbid conditions to those that were significantly associated with POM. This final model had a c statistic of 0.719 and an AIC of 4,960. The Hosmer and Lemeshow test showed that this model had an adequate fit (P 5 0.670). We then divided our cohort into quintiles, with the first quintile representing those with the smallest predicted probability of 30-day death, and the fifth quintile representing those patients that the model predicted would have the highest likelihood of POM. Figure 2 shows that as a predictive risk score increased from the first to the fifth quintile, the observed mortality increased from 1.2 to more than 10%.
DISCUSSION
Although surgical resection is the only means to obtain good longterm outcomes for patients with localized NSCLC, physicians often have concerns about perioperative deaths, particularly among elderly patients. In this study, we validated and refined a model to predict POM on a large cohort of elderly patients with stage I-IIIA NSCLC. Our results show that this model can be used to stratify patients into groups with considerably different risks of POM. Identification of patients with low risk of POM may increase use of surgery within the elderly, whereas identification of those at high risk can help inform decision making and select candidates for targeted interventions to reduce POM.
The decision to operate on elderly patients with lung cancer with multiple comorbidities or limited life expectancy can be difficult. Patients, clinicians, and surgeons are required to weigh the potential long-term benefits of surgery against the risk of perioperative death (25) . Strand and colleagues (11) derived a clinical prediction rule to aide this decision-making process, using data from 4,395 patients (1,844 with available comorbidity data) from the Cancer Registry of Norway. In that study, the investigators showed that the model was able to identify a subset of patients at increased risk of 30-day POM. However, the derivation of a model is only the first step in the development of a clinical prediction rule. Before a predictive model can be used clinically, it must also go through external validation, as well as an impact analysis (13) . Validation is essential to ensure that the original model is applicable to other patient populations. During the derivation process, it may occur that some of the predictive variables included in the model are unique to the study population, and therefore cannot be generalized to other settings. Thus, the clinical rule must be validated in independent populations with varying spectrum of disease and different demographic characteristics to demonstrate the reproducibility of the model's predictive ability (26) . Finally, impact analysis is necessary to determine whether the prediction rule is easy to use in routine care and to assess if its use is beneficial to patient care (27) . In this study, we showed that the model was able to predict the risk of POM among a large cohort of elderly patients with NSCLC-a population at increased risk of surgical complications. Thus, our results strongly support the generalizability of the prediction model. The overall 30-day mortality of 4.6% in our study was similar to the 5.2% rate reported by the American College of Sur- 
Congestive heart failure -- (11) is limited to the 1,844 patients that have comorbidity data available (which were from years 1993-1998).
geons in a national hospital survey (28) . Similarly, a study by Memtsoudis and colleagues (29) , using data from the National Hospital Discharge Survey, found a POM of 4.8%. As previously reported, POM varied considerably according to the type of procedure-3.6% after lobectomy compared with 13.1% after pneumonectomy. When compared with studies including older patients, Strand and colleagues (11) reported POM of 4.1% for lobectomy/limited resection, and 13.7% for pneumonectomy among patients older than 70 years of age. A study using a smaller cohort of patients from a single center found a POM rate of 5.0% for lobectomy and 8.0% for pneunectomy among octogenarians (30) .
There are several potential uses of this model. First, the predictive model can help inform the discussion between elderly patients and clinicians about treatment options for potentially resectable lung cancers. Additionally, surgery is underused in the elderly, with concerns of morbidity and mortality trumping the potential benefits of curative resection (4, 6, 9, 31) . A clinical prediction rule can help identify low-risk patients, and thus reassure physicians that surgery is appropriate. Thus, the implementation of this rule could lead to increases in surgery rates among the elderly by illuminating the low probability of a fatal complication. This model could also identify patients at the highest risk of POM. Because lung resection is the only definitively curative treatment, it may still be the best option, even among the highest-risk patients (with POM . 10%). However, the identification of these patients may be useful for ordering additional preoperative tests, providing close postoperative monitoring, or implementing targeted interventions to reduce their POM. Lastly, the predictive model can be used for risk adjustment to compare surgical outcomes among different institutions or for public reporting. This model is particularly well suited for such institutional comparisons, because it makes use of administrative data that should be easily available to hospital administrators.
There are some strengths and limitations of this study that should be mentioned. As SEER-Medicare is a population-based cancer registry, the generalizability of the model should be strong. Because our study was limited to patients older than 65 years of age, this clinical rule still must be validated in a younger population. However, the elderly are at higher risk for POM and, as a result, there is a greater need for a clinical rule for these patients. Additionally, both the initial study by Strand and colleagues and the SEER-Medicare registry lacked data on pulmonary function tests and other pulmonary performance measures; thus, we are not able to asses whether their inclusion would improve the accuracy of the rule. Information regarding hospital volume and surgical technique (video-assisted thoracic surgery versus open thoracotomy) were not available in SEERMedicare, and, thus, are not included in our model. However, these variables were not significant predictors of 30-day POM in the model published by Strand and colleagues, and their exclusion should not have affected the model substantially.
In conclusion, risk assessment is critical for physicians to make decisions about the best therapy for their lung cancer patients, and particularly for the elderly, who are at high risk for POM. In this study, we validated and refined a previously derived prediction rule, showing that it can be used to stratify these patients Figure 1 . Refinement of the predictive model. Each logistic model was compared using the Akaiki information criteria (AIC) and the c statistic. A low AIC indicates better goodness of fit, whereas a higher c statistic denotes improved discrimination of a model. The validation model used the same risk factors as the initial model by Strand and colleagues. Histology and age were then redefined to include large-cell carcinoma and bronchoalveolar carcinoma as separate histologic groups, and ages 70-75 and 75-80 years as individual age groups. The subsequent model used all individual comorbidities instead of the composite comorbidity score. Only five comorbidities were statistically significant predictors, and, thus, were included in the final refined model.
according to their risk of 30-day POM. An impact analysis is necessary to assess if routine use of the rule in clinical practice improves the management and outcomes of elderly patients with potentially resectable NSCLC. Figure 2 . Predicted versus observed rates of perioperative mortality (POM). Using the final refined model, patients were divided into predicted risk quintiles, with quintile 1 representing the lowest-risk group. The predicted and observed rates of 30-day POM was assessed for each quintile.
